Important note: Information in this article was accurate in 2006. The state of the art may have changed since the publication date.
|
|
Wall Street Journal - May 10, 2006
Marilyn Chase, marilyn.chase@wsj.com
Stephen Udem, vice president of exploratory vaccine discovery research at Wyeth Vaccines Research, a unit of Wyeth, will become IAVI's senior vice president of vaccine development. He succeeds Emilio Emini, who left IAVI in December to join Wyeth. Dr. Udem also will hold the title of chief scientific officer at IAVI. His appointment is effective June 1.
John McGoldrick, executive vice president of Bristol-Myers Squibb Co. in charge of law, government affairs, philanthropy and global policy, will join IAVI as senior vice president of external strategy development, a new post focused on fund raising and resources management. Mr. McGoldrick's appointment is effective May 30.
IAVI has helped to put six AIDS vaccine products into human tests around the world, and tested a seventh in collaboration with the Vaccine Research Center of the National Institutes of Health. IAVI has five vaccine clinical trials under way.
IAVI, which is funded by governments, corporations, philanthropies and individuals, advances AIDS vaccines through product-development partnerships with pharmaceutical companies. IAVI finances research and development, including clinical trials, for AIDS vaccine candidates.
Seth Berkley, IAVI's president and chief executive officer, said in an interview that AIDS vaccine work is accelerating. "You've got extremely difficult science, but we're moving into a renaissance," he said. He cited forthcoming data from several vaccines that spark a cellular immune response, and a push to crack the challenge of making neutralizing antibodies to block infection.
060510
WJ060505
Copyright © 2006 - The Wall Street Journal. Reproduction of this article (other than one copy for personal reference) must be cleared through the WSJ Permissions Desk.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .